Manufacturers/Sanofi-Aventis U.S. LLC

Sanofi-Aventis U.S. LLC

54 drugs in NADAC|17 Generic,37 Brand

View Recalls (22)

Total Drugs

54

17G / 37B

Avg Price / Unit

$200.2469

$0.11 – $2079.82

Avg 7d Change

-1.50%

Across 20 drugs with changes

7d Activity

81234 flat

of 54 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

54 drugs total, 54 shown

Drug Price 7d Change
KEVZARA 200 MG/1.14 ML PEN INJ
sarilumab
$2079.8200
per ML
KEVZARA 200 MG/1.14 ML SYRINGE
sarilumab
$2066.4821
per ML
DUPIXENT 200 MG/1.14 ML SYRING
Dupilumab
$1774.7544
per ML
DUPIXENT 200 MG/1.14 ML PEN
Dupilumab
$1772.9914
per ML
DUPIXENT 300 MG/2 ML SYRINGE
Dupilumab
$1009.9578
per ML
DUPIXENT 300 MG/2 ML PEN
Dupilumab
$1008.4070
per ML
LOVENOX 120 MG/0.8 ML SYRINGE
enoxaparin sodium
$121.2131
per ML
TOUJEO SOLOSTAR 300 UNIT/ML
insulin glargine
$91.3482
per ML
-0.01%
TOUJEO MAX SOLOSTR 300 UNIT/ML
insulin glargine
$91.2771
per ML
0.00%
LOVENOX 30 MG/0.3 ML SYRINGE
enoxaparin sodium
$80.8740
per ML
LOVENOX 60 MG/0.6 ML SYRINGE
enoxaparin sodium
$80.5583
per ML
LOVENOX 100 MG/ML SYRINGE
enoxaparin sodium
$80.1367
per ML
LOVENOX 100 MG/ML SYRINGE
enoxaparin sodium
$80.1367
per ML
SOLIQUA 100 UNIT-33 MCG/ML PEN
insulin glargine and lixisenatide
$57.0731
per ML
+0.03%
ARAVA 20 MG TABLET
leflunomide
$37.8444
per EA
INSULIN GLARGINE MAX SOLO U300
insulin glargine
$26.9595
per ML
INSULIN GLARGINE SOLOSTAR U300
insulin glargine
$26.9353
per ML
AMBIEN 10 MG TABLET
zolpidem tartrate
$22.5808
per EA
AMBIEN CR 12.5 MG TABLET
zolpidem tartrate
$22.5728
per EA
AMBIEN CR 6.25 MG TABLET
zolpidem tartrate
$20.6528
per EA
AMBIEN 5 MG TABLET
zolpidem tartrate
$20.6203
per EA
MULTAQ 400 MG TABLET
Dronedarone
$13.1941
per EA
ADMELOG 100 UNIT/ML VIAL
insulin lispro
$12.5670
per ML
+0.07%
ADMELOG SOLOSTAR 100 UNIT/ML
insulin lispro
$12.1147
per ML
-0.01%
ENOXAPARIN 120 MG/0.8 ML SYR
enoxaparin sodium
$11.9737
per ML
-9.11%
ENOXAPARIN 300 MG/3 ML VIAL
enoxaparin sodium
$10.9742
per ML
-2.32%
ENOXAPARIN 150 MG/ML SYRINGE
enoxaparin sodium
$10.9407
per ML
-5.62%
APIDRA SOLOSTAR 100 UNIT/ML
insulin glulisine
$10.4984
per ML
-0.04%
AVALIDE 300-12.5 MG TABLET
irbesartan and hydrochlorothiazide
$9.7125
per EA
ENOXAPARIN 30 MG/0.3 ML SYR
enoxaparin sodium
$9.5701
per ML
+1.58%
ADMELOG 100 UNIT/ML VIAL
insulin lispro
$9.3935
per ML
-0.01%
LOVENOX 80 MG/0.8 ML SYRINGE
enoxaparin sodium
$8.9735
per ML
LOVENOX 80 MG/0.8 ML SYRINGE
enoxaparin sodium
$8.9735
per ML
AVALIDE 150-12.5 MG TABLET
irbesartan and hydrochlorothiazide
$8.9109
per EA
AVAPRO 300 MG TABLET
irbesartan
$8.7987
per EA
+0.01%
ENOXAPARIN 60 MG/0.6 ML SYR
enoxaparin sodium
$8.4061
per ML
+0.91%
PLAVIX 75 MG TABLET
clopidogrel
$8.2182
per EA
ENOXAPARIN 100 MG/ML SYRINGE
enoxaparin sodium
$8.1982
per ML
-4.13%
APIDRA 100 UNIT/ML VIAL
insulin glulisine
$8.1717
per ML
-0.04%
ENOXAPARIN 40 MG/0.4 ML SYR
enoxaparin sodium
$7.9043
per ML
-0.76%
ENOXAPARIN 80 MG/0.8 ML SYR
enoxaparin sodium
$7.6158
per ML
-3.20%
AVAPRO 150 MG TABLET
irbesartan
$7.3655
per EA
+0.01%
LOVENOX 40 MG/0.4 ML SYRINGE
enoxaparin sodium
$6.7750
per ML
LOVENOX 40 MG/0.4 ML SYRINGE
enoxaparin sodium
$6.7750
per ML
LANTUS SOLOSTAR 100 UNIT/ML
insulin glargine
$6.1661
per ML
0.00%
LANTUS 100 UNIT/ML VIAL
insulin glargine
$6.1584
per ML
0.00%
PRIFTIN 150 MG TABLET
rifapentine
$4.8468
per EA
SEVELAMER 2.4 GM POWDER PACKET
Sevelamer Carbonate
$2.0075
per EA
PRIMAQUINE 26.3 MG TABLET
Primaquine Phosphate
$1.9639
per EA
SEVELAMER 0.8 GM POWDER PACKET
Sevelamer Carbonate
$1.7318
per EA
SEVELAMER HCL 800 MG TABLET
Sevelamer Hydrochloride
$0.7910
per EA
-7.64%
SEVELAMER CARBONATE 800 MG TAB
Sevelamer Carbonate
$0.2163
per EA
ZOLPIDEM TART ER 6.25 MG TAB
zolpidem tartrate
$0.1171
per EA
+0.20%
ZOLPIDEM TART ER 12.5 MG TAB
zolpidem tartrate
$0.1109
per EA
+0.07%

FDA Recalls (22)

Recalls matched by company name. Verify current status with FDA.

D-0575-2023
Ongoing
Class II

Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial, Rx Only, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807 A Sanofi Company. NDC 0024-5926-05

Lack of Assurance of Sterility: Malformed crimped collar seal

Initiated: 4/11/2023
D-1507-2020
Ongoing
Class II

Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75

Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.

Initiated: 8/10/2020
D-0540-2020
Ongoing
Class II

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 50269-222-25.

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0542-2020
Ongoing
Class II

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 67751-152-01 67751-152-02

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0544-2020
Ongoing
Class II

Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 66715-9736-2 66715-9736-3 66715-9736-8

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0537-2020
Ongoing
Class II

Regular Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 05269-220-25.

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0534-2020
Ongoing
Class II

Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's: 0597-0120-06, 0597-0120-08, 0597-0120-09, 0597-0120-24, 0597-0120-38, 0597-0120-50, 0597-0120-76, 0597-0120-78, 0597-0120-80, 0597-0120-82, 0597-0120-87.

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0535-2020
Ongoing
Class II

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219 NDC's 41167-0300-0, 41167-0300-1, 41167-0300-3, 41167-0300-5, 41167-0300-6, 41167-0300-7, 41167-0300-8

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0536-2020
Ongoing
Class II

Maximum Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 41167-0310-1 41167-0310-2 41167-0310-3 41167-0310-4 41167-0310-6 41167-0310-7 41167-0310-8

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0539-2020
Ongoing
Class II

Maximum Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's: 0597-0121-01, 0597-0121-06, 0597-0121-08, 0597-0121-09, 0597-0121-11, 0597-0121-24, 0597-0121-38, 0597-0121-50, 0597-0121-64, 0597-0121-66, 0597-0121-68, 0597-0121-78, 0597-0121-80, 0597-0121-82, 0597-0121-85, 0597-0121-90, 0597-0121-94.

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0538-2020
Ongoing
Class II

Cool Mint Maximum Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219 NDC's: 41167-0320-1 41167-0320-2 41167-0320-3 41167-0320-4 41167-0320-5 41167-0320-6 41167-0320-7

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0543-2020
Ongoing
Class II

Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 68151-2584-0.

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0541-2020
Ongoing
Class II

Regular Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 67751-151-01.

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0545-2020
Ongoing
Class II

Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 0597-0122-01 0597-0122-08 0597-0122-13 0597-0122-37 0597-0122-40 0597-0122-54 0597-0122-61 0597-0122-81 0597-0122-96

CGMP Deviations: Presence of NDMA impurity detected in product.

Initiated: 10/22/2019
D-0925-2018
Ongoing
Class II

Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Initiated: 7/5/2018
D-0804-2018
Terminated
Class II

Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01

Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.

Initiated: 4/27/2018
D-0153-2018
Terminated
Class III

Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10

Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL

Initiated: 12/5/2017
D-0056-2018
Terminated
Class III

Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Initiated: 10/13/2017
D-0926-2017
Terminated
Class III

Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.

Superpotent Drug: high out-of-specification result for magnesium.

Initiated: 6/12/2017
D-0704-2017
Terminated
Class III

Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01

Labeling: Incorrect or Missing Package Insert

Initiated: 9/1/2016
D-0873-2016
Terminated
Class I

Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company

Defective Delivery System; potential to have inaccurate dosage delivery

Initiated: 10/28/2015
D-0872-2016
Terminated
Class I

Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.3 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0025-5833-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5833-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company

Defective Delivery System; potential to have inaccurate dosage delivery

Initiated: 10/28/2015